Du, Fei
- McLean Hospital · Neurology (topic-inferred)
- McLean Hospital · Psychiatry (topic-inferred)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #7,097
- Rising Star
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.3M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#7,097
By linked amount among FY2023 PIs
Earliest Year Loaded
2011
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Du, Fei as a PI. Multi-PI records show the full award amount for context.
- 5R01AG066670-04R01Contact PIEffects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's DementiaMcLean Hospital · Neurology (topic-inferred)$886.3Kaward amount
- 5R01MH114982-05R01Contact PIMolecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early PsychosisMcLean Hospital · Psychiatry (topic-inferred)$424.1Kaward amount
Award organization
Organizations that administered FY2023 awards listing Du, Fei as a PI.
FY2023 award administered by McLean Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardMcLean Hospital
- 2017$500K Cumulative Funding
- 2018R01 Grant Holder
- 2019$1M Cumulative Funding
- 2020$2M Cumulative Funding
- 2020Entered Top 50% NationallyRanked #2573
- 2020Entered Top 25% NationallyRanked #2573
- 2022$5M Cumulative Funding